Literature DB >> 18093889

P2Y receptors activated by diadenosine polyphosphates reestablish Ca(2+) transients in achondroplasic chondrocytes.

Ana Guzmán-Aránguez1, Marta Irazu, Avner Yayon, Jesús Pintor.   

Abstract

Achondroplasia is the most common type of dwarfism, characterised by a mutation in the gene that encodes the fibroblast growth factor receptor 3 (FGFR3). Achondroplasia mainly affects the chondrocytes and therefore bones do not grow properly since intracellular pathways are altered. In this sense, defective calcium signaling by mutant FGFR3 has been previously described. The purpose of this study was to investigate the presence of purinergic P2Y receptors and how the activation of these receptors can have influence on defective calcium signaling observed in achondroplasic chondrocytes. The presence of P2Y receptors was determined by immunocytochemical and western blot techniques. Calcium mobilization after stimulation with nucleotides, dinucleotides, or, FGF9 application, was measured using the ratiometric dye fura-2/AM and fluorescence imaging. Our results demonstrate the expression of P2Y(1), P2Y(2), P2Y(6) and P2Y(11) receptors in achondroplasic chondrocytes, as well as the activation of these receptors after nucleotides and dinucleotides exposure. The altered calcium signaling of achondroplasic chondrocytes was confirmed, since FGF9 treatment fails to induce calcium mobilization. However, achondroplasic chondrocytes pre-treated with Ap(4)A are able to respond with increases in intracellular calcium after FGF9 stimulation. These findings show the rescue effect of diadenosine tetraphosphate (Ap(4)A), acting by means of P2Y receptors, on defective calcium response triggered by achondroplasic FGFR3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093889     DOI: 10.1016/j.bone.2007.10.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  A critical look at the function of the P2Y11 receptor.

Authors:  Karin Dreisig; Birgitte Rahbek Kornum
Journal:  Purinergic Signal       Date:  2016-05-31       Impact factor: 3.765

Review 3.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

4.  Effects of diadenosine tetraphosphate on FGF9-induced chloride flux changes in achondroplastic chondrocytes.

Authors:  Fernando Huete; Ana Guzman-Aranguez; Javier Ortín; Charles H V Hoyle; Jesús Pintor
Journal:  Purinergic Signal       Date:  2011-05-11       Impact factor: 3.765

5.  Using antibodies against P2Y and P2X receptors in purinergic signaling research.

Authors:  Dovrat Brass; Melanie R Grably; Noemi Bronstein-Sitton; Ofra Gohar; Alon Meir
Journal:  Purinergic Signal       Date:  2011-11-16       Impact factor: 3.765

6.  Extracellular Nucleotides Selectively Induce Migration of Chondrocytes and Expression of Type II Collagen.

Authors:  Marcin Szustak; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

7.  The impact of polyphenols on chondrocyte growth and survival: a preliminary report.

Authors:  Salvador Fernández-Arroyo; Fernando Huete-Toral; María Jesús Pérez de Lara; María de la Luz Cádiz-Gurrea; Laurence Legeai-Mallet; Vicente Micol; Antonio Segura-Carretero; Jorge Joven; Jesús Pintor
Journal:  Food Nutr Res       Date:  2015-10-05       Impact factor: 3.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.